Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine

Clinical Trials: Bipolar Disorder


A listing of clinical trials currently looking for volunteers to enroll in Bipolar Disorder studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Forest Investigative Site 021

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Dothan : Call for Information (Investigational Site 0018)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Dothan : Call for Information (Investigational Site 0018)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Arizona

Scottsdale : Call for Information (Investigational Site 0006)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Scottsdale : Call for Information (Investigational Site 0006)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Arkansas

Little Rock : Call for Information (Investigational Site 0011)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Little Rock : Call for Information (Investigational Site 0086)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Little Rock : Call for Information (Investigational Site 0011)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Little Rock : Call for Information (Investigational Site 0086)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

California

Cerritos : Comprehensive Clinical Development - Cerritos, CA

Bipolar Depression

Cerritos : Comprehensive Clinical Development - Cerritos, CA

Bipolar Disorder ITN# 11928CA

Imperial : Sun Valley Research Center

Do you suffer from Bipolar Depression?

Sherman Oaks : Schuster Medical Research Institute

Do You suffer from Bipolar Depression?

View More »

Anaheim : Call for Information (Investigational Site 0013)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Anaheim : Call for Information (Investigational Site 0013)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Beverly Hills : Forest Investigative Site 030

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cerritos : Forest Investigative Site 018

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Colton : Call for Information (Investigational Site 0085)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Colton : Call for Information (Investigational Site 0085)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Costa Mesa : ATP Clinical Research, Inc.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Costa Mesa : Call for Information (Investigational Site 0107)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Costa Mesa : Call for Information (Investigational Site 0107)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Costa Mesa : Forest Investigative Site 028

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Downey : Diligent Clinical Trials

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Escondido : Synergy Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Escondido : Call for Information (Investigational Site 0061)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Escondido : Call for Information (Investigational Site 0061)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Garden Grove :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Glendale :

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Los Angeles :

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Murrieta : Call for Information (Investigational Site 0083)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Murrieta : Call for Information (Investigational Site 0083)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

National City :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Oceanside : Forest Investigative Site 015

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Orange :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Paramount :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Pico Rivera :

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

San Diego : Call for Information (Investigational Site 0035)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

San Diego : Call for Information (Investigational Site 0043)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

San Diego :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

San Diego : Call for Information (Investigational Site 0043)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

San Diego : Call for Information (Investigational Site 0035)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

San Diego :

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

San Diego : Forest Investigative Site 022

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

San Francisco : Call for Information (Investigational Site 0021)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

San Francisco : Call for Information (Investigational Site 0021)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Santa Ana : Call for Information (Investigational Site 0096)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Santa Ana :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Santa Ana : Call for Information (Investigational Site 0096)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Stanford : Call for Information (Investigational Site 0009)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Stanford : Call for Information (Investigational Site 0009)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Temecula : Forest Investigative Site 011

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Torrance :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Wildomar :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Colorado

Colorado Springs : Call for Information (Investigational Site 0067)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Colorado Springs : Call for Information (Investigational Site 0067)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Connecticut

Hartford : Call for Information (Investigational Site 0033)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Hartford : Call for Information (Investigational Site 0033)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Norwalk :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

District of Columbia

Washington : Comprehensive Clinical Development - Washington, DC

Biopolar Disorder ITN# 11928DC

View More »

Washington : Call for Information (Investigational Site 0060)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Washington : Call for Information (Investigational Site 0065)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Washington :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Washington : Call for Information (Investigational Site 0060)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Washington : Call for Information (Investigational Site 0065)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Florida

Bradenton : Florida Clinical Research Center - Bradenton/Sarasota

Feeling Down or Sad?

Miami : Pharmax Research Clinic, Inc.

Bipolar Disorder Type I

Miami : Pharmax Research Clinic, Inc.

Males and Females between 18 and 90 years of age, suffering of Bipolar Disorder Type I for at least two years.

View More »

Fort Myers :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Gainesville : Call for Information (Investigational Site 0048)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Gainesville : Call for Information (Investigational Site 0048)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Hollywood : Segal Institute for Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Jacksonville :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Jacksonville : Forest Investigative Site 012

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Jacksonville Beach : Call for Information (Investigational Site 0025)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Jacksonville Beach : Call for Information (Investigational Site 0025)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Juno Beach : Advanced Mental Health Care Inc. - Juno Beach

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Lauderhill : Call for Information (Investigational Site 0051)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Lauderhill : Call for Information (Investigational Site 0051)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Orange City : Call for Information (Investigational Site 0056)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Orange City :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Orange City : Call for Information (Investigational Site 0056)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Orlando : Call for Information (Investigational Site 0026)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Orlando : Call for Information (Investigational Site 0026)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Orlando : Forest Investigative Site 035

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Royal Palm Beach : Advanced Mental Health Care Inc. - Royal Palm Beach

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Tampa : Call for Information (Investigational Site 0005)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Tampa :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Tampa : Call for Information (Investigational Site 0005)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Winter Park : Forest Investigative Site 013

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Georgia

Atlanta : Comprehensive Clinical Development - Atlanta, GA

Do you suffer from Bipolar Depression? ITN# 11312

Atlanta : Comprehensive Clinical Development - Atlanta, GA

Do you suffer from Bipolar Depression? ITN#09343

View More »

Atlanta : Call for Information (Investigational Site 0045)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Atlanta : Call for Information (Investigational Site 0045)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Atlanta : Forest Investigative Site 005

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Atlanta : Forest Investigative Site 038

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Smyrna : Call for Information (Investigational Site 0003)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Smyrna :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Smyrna : Call for Information (Investigational Site 0003)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Idaho

Coeur d'Alene : Call for Information (Investigational Site 0090)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Coeur d'Alene : Call for Information (Investigational Site 0090)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Illinois

Chicago : Rush University Medical Center - Treatment Research Center

Preventing the Recurrence of Depression in Bipolar Disorder

Hoffman Estates : Alexian Brothers Hospital Network

A double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with acute mania associated with Bipolar I Disorder

Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.

Depression in Bipolar Disorder - Relapse Prevention

View More »

Chicago : NPI, University of Illinois at Chicago

Lamotrigine Monotherapy in Pediatric Bipolar Disorder

Chicago : Forest Investigative Site 029

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Libertyville : Call for Information (Investigational Site 0017)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Libertyville : Call for Information (Investigational Site 0017)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Naperville : Call for Information (Investigational Site 0004)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Naperville : Call for Information (Investigational Site 0004)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Naperville :

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Skokie :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Indiana

Indianapolis : Forest Investigative Site 024

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Terre Haute : Call for Information (Investigational Site 0019)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Terre Haute : Call for Information (Investigational Site 0019)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Kansas

Prairie Village : Forest Investigative Site 031

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Wichita : Call for Information (Investigational Site 0049)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Wichita : Call for Information (Investigational Site 0049)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Louisiana

Lake Charles : Call for Information (Investigational Site 0058)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Lake Charles : Call for Information (Investigational Site 0058)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Shreveport : Call for Information (Investigational Site 0062)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Shreveport :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Shreveport : Call for Information (Investigational Site 0062)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Maryland

Baltimore : Johns Hopkins University

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Towson : Forest Investigative Site 001

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Massachusetts

Haverhill : ActivMed Practices & Research, Inc.

Are you or a loved one suffering from symptoms of Bipolar Disorder?

Haverhill : ActivMed Practices & Research, Inc.

Are you or a loved one suffering from symptoms of Bipolar Disorder?

View More »

Cambridge : Call for Information (Investigational Site 0101)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Cambridge : Call for Information (Investigational Site 0101)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Cambridge : Cambridge Health Alliance

Ropinirole in the Treatment of Bipolar Depression

Mississippi

Flowood : Call for Information (Investigational Site 0080)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Flowood :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Flowood : Call for Information (Investigational Site 0080)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Missouri

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Bipolar Disorder Research Study Seeks Volunteers.

View More »

Creve Coeur : Call for Information (Investigational Site 0081)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Creve Coeur : Call for Information (Investigational Site 0081)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Creve Coeur : Forest Investigative Site 026

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St Louis :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

St. Louis : Scientella LLC

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Nebraska

Lincoln : Call for Information (Investigational Site 0071)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Lincoln : Call for Information (Investigational Site 0071)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Nevada

Las Vegas : Forest Investigative Site 037

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

New Jersey

Cherry Hill :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Cherry Hill : Forest Investigative Site 023

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Marlton : CRI Lifetree

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Willingboro : Forest Investigative Site 014

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

New Mexico

Albuquerque : Forest Investigative Site 006

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

New York

Bronx : Biomedical Research Alliance of New York Updated

Bipolar Disorder

Bronx : Biomedical Research Alliance of New York

Bipolar Disorder

Fresh Meadows : Comprehensive Clinical Development - Queens, NY

olar Disorder ITN# 11928NY

New York : Medical & Behavioral Health Research, PC

Bipolar Depression

New York : Medical & Behavioral Health Research, PC

Bipolar Depression Research Study

View More »

Amherst : Call for Information (Investigational Site 0007)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Amherst : Call for Information (Investigational Site 0007)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Brooklyn : Forest Investigative Site 003

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cedarhurst :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Fresh Meadows :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Glen Oaks : The Zucker Hillside Hospital

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Glen Oaks : Call for Information (Investigational Site 0079)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Glen Oaks : Call for Information (Investigational Site 0079)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

New York :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

New York : Mount Sinai Hospital

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

New York :

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

New York : Forest Investigative Site 025

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Rochester : Call for Information (Investigational Site 0002)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Rochester :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Rochester : Call for Information (Investigational Site 0002)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Staten Island : Call for Information (Investigational Site 0104)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Staten Island : Call for Information (Investigational Site 0104)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Stonybrook : Call for Information (Investigational Site 0008)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Stonybrook : Call for Information (Investigational Site 0008)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

North Carolina

Wilmington : PMG Research of Wilmington

Have you been diagnosed with Bipolar Disorder?

View More »

Durham : Forest Investigative Site 004

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Raleigh :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Ohio

Avon Lake : Call for Information (Investigational Site 0001)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Avon Lake : Call for Information (Investigational Site 0001)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Canton : Call for Information (Investigational Site 0032)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Canton : Call for Information (Investigational Site 0032)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Canton : Forest Investigative Site 036

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

View More »

Cincinnati : Call for Information (Investigational Site 0010)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Cincinnati : Call for Information (Investigational Site 0010)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Cleveland : Call for Information (Investigational Site 0015)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Cleveland : Call for Information (Investigational Site 0015)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Cleveland : University Hospitals Case Medical Center

Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Dayton : Midwest Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Dayton :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Dayton : Forest Investigative Site 008

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Garfield Heights : Call for Information (Investigational Site 0044)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Garfield Heights : Call for Information (Investigational Site 0044)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Mason : Lindner Center of HOPE

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Mason : Lindner Center of HOP

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Oklahoma

Oklahoma City : Call for Information (Investigational Site 0050)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Oklahoma City : Call for Information (Investigational Site 0070)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Oklahoma City : Call for Information (Investigational Site 0023)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Oklahoma City : Call for Information (Investigational Site 0078)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Oklahoma City : Call for Information (Investigational Site 0078)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

View More »

Oklahoma City : Call for Information (Investigational Site 0023)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Oklahoma City : Call for Information (Investigational Site 0050)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Oklahoma City : Call for Information (Investigational Site 0070)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Tulsa : Call for Information (Investigational Site 0100)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Tulsa : Call for Information (Investigational Site 0100)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Oregon

Portland : Summit Research Network (Oregon), Inc.

Are you struggling with the mood swings of bipolar disorder?

Portland : Summit Research Network (Oregon), Inc.

Bipolar Clinical Research Study

View More »

Portland :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Pennsylvania

Media : Suburban Research Associates

Have you been diagnosed with Bipolar Disorder and are taking mood stabilizer medication?

View More »

Allentown : Lehigh Center for Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Allentown :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Allentown : Forest Investigative Site 009

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Dubois : Dubois Regional Medical Center

Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder

Media : Forest Investigative Site 010

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Philadelphia : Call for Information (Investigational Site 0031)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Philadelphia : Call for Information (Investigational Site 0031)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Pittsburgh : Western Psychiatric Institute and Clinic

Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder

Rhode Island

Lincoln : Lincoln Research - Rhode Island

Suffering from bipolar depression and are depressed and on medication?

South Carolina

Charleston : Call for Information (Investigational Site 0012)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Charleston : Call for Information (Investigational Site 0091)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Charleston : Call for Information (Investigational Site 0012)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Charleston : Call for Information (Investigational Site 0091)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Charleston : Medical University of South Carolina

Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine

Tennessee

Memphis : Call for Information (Investigational Site 0054)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Memphis : Call for Information (Investigational Site 0054)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Memphis : Forest Investigative Site 019

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Texas

Dallas : Research Across America

Adolescent Bipolar Type I Research Study

Dallas : Research Across America

Bipolar Type I Research Study

Houston : Bayou City Research Corporation

Bipolar Depression study with 6-month open-label therapy

Houston : Bayou City Research Corporation

Do your moods go up and down like a rollercoster?

Lake Jackson : R/D Clinical Research, Inc.

A Randomized, Double-Bllind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects with BiPolar I Disorder

Lake Jackson : R/D Clinical Research, Inc.

Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated with Bipolar I Disorder

View More »

Ausitn : Senior Adults Specialty Research

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Austin : Call for Information (Investigational Site 0072)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Austin : Call for Information (Investigational Site 0072)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Dallas : Call for Information (Investigational Site 0037)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Dallas :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Dallas : Call for Information (Investigational Site 0037)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Dallas : UT Southwestern Medical Center at Dallas

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Dallas : Forest Investigative Site 007

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

DeSoto : Call for Information (Investigational Site 0053)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

DeSoto : Call for Information (Investigational Site 0053)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Houston : Claghorn-Lesem Research Clinic

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Houston : Call for Information (Investigational Site 0016)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Houston : Call for Information (Investigational Site 0097)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Houston :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Houston : Call for Information (Investigational Site 0016)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Houston : Call for Information (Investigational Site 0097)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Houston : Forest Investigative Site 016

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Houston : Forest Investigative Site 027

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Lake Jackson : Call for Information (Investigational Site 0024)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

San Antonio : Univ of Texas Helath Science Center at San Antonio

12- Week Open Label Treatment of Refractory Bipolar Depression

San Antonio : Forest Investigative Site 020

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

San Antonio : Forest Investigative Site 034

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

The Woodlands : Call for Information (Investigational Site 0105)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

The Woodlands : Call for Information (Investigational Site 0105)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Wharton : Call for Information (Investigational Site 0041)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Wharton : Call for Information (Investigational Site 0041)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Utah

Salt Lake City : CRI Lifetree

To assess the efficacy of ELND005 compared to placebo as adjunctive maintenance therapy in patients with BPD I, as evidenced by a delay in the time to recurrence of any type of mood episode in the randomized phase of the study

View More »

Salt Lake City : Lifetree Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Salt Lake City : Call for Information (Investigational Site 0063)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Salt Lake City : Call for Information (Investigational Site 0063)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Virginia

Charlottesville : Call for Information (Investigational Site 0093)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Charlottesville : Call for Information (Investigational Site 0093)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Washington

Seattle : Summit Research Network (Seattle) LLC

Are you dealing with Bipolar Disorder?

Seattle : Summit Research Network (Seattle) LLC

Bipolar Disorder Research Study

View More »

Bothell : Call for Information (Investigational Site 0039)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Bothell : Call for Information (Investigational Site 0039)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Bothell :

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Kirkland : Call for Information (Investigational Site 0029)

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)

Kirkland :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Kirkland : Call for Information (Investigational Site 0029)

Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)

Richland : Scientella, LLC.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Seattle :

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients

Seattle : Forest Investigative Site 032

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Tacoma and Seattle : VA Puget Sound Health Care System

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Bulgaria

Pleven : Forest Investigative Site 302

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Plovdiv : Forest Investigative Site 301

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Sofia : Forest Investigative Site 306

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Canada

Chatham : Forest Investigative Site 101

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Hamilton : St. Joseph's Healthcare, Centre for Mountain Health Services

Longitudinal Study of People Presenting for First Treatment of a Mood Disorder

Kelowna : Okanagan Clinical Trials

Lurasidone Extended Use Study

Kelowna : Forest Investigative Site 102

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Medicine Hat : Forest Investigative Site 104

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

View More »

Montréal : Douglas Mental Health University Institute

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

Penticton : Forest Investigative Site 103

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Toronto : University Health Network - Toronto General Division

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Toronto : University Health Network - Toronto Western Division

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Toronto : Sunnybrook Health Sciences Centre

Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder

Vancouver : BC Mental Health & Addictions Research Institute

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

Vancouver : Institute of Mental Health, University of British Columbia

What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?

China

Baoding : GSK Investigational Site

Lamotrigine Phase III Study in Bipolar I Disorder

Beijing : GSK Investigational Site

Lamotrigine Phase III Study in Bipolar I Disorder

Beijing : Institute of mental health, Peking University

The Third Survey of Prescription Pattern of Psychotropic Drugs in China

Kunming : GSK Investigational Site

Lamotrigine Phase III Study in Bipolar I Disorder

Shanghai : GSK Investigational Site

Lamotrigine Phase III Study in Bipolar I Disorder

Colombia

Barranquilla : Centro de Investigaciones y Proyectos en Neurociencias CIPNA Investigations

Lurasidone Extended Use Study

Bello : E.S.E. Hospital Mental de Antioquia

Lurasidone Extended Use Study

La Ceja : Clínica San Juan de Dios

Effect of Pharmaceutical Care in Patients With Bipolar I Disorder (BD I)

Czech Republic

Brno-mesto : Psychiatricka ambulance

Lurasidone Extended Use Study

Olomouc : Vojenska nemocnice Olomouc

Lurasidone Extended Use Study

Praha : Medical Services Prague s.r.o.

Lurasidone Extended Use Study

Praha : Clintrial, s.r.o.

Lurasidone Extended Use Study

Denmark

Copenhagen : Psychiatric Centre Copenhagen, Rigshospitalet, Denmark

The Effects of Cognitive Remediation on Remitted Bipolar Disorder - a Proof of Concept Study

France

Orvault : Zans Ritter, Marcel

Lurasidone Extended Use Study

India

Israel

Hod Hasharon : shalvataMHC

Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression

Japan

Chubu :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Chugoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Hokkaido :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Hokkaido :

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Kansai :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

View More »

Kanto :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Kyushu :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Shikoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Touhoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Lithuania

Kaunas : JSC Neuromeda

Lurasidone Extended Use Study

Kaunas : Neuromeda JSC

Lurasidone Extended Use Study

Vilnius : Seskines Outpatient Clinic, Public Institution

Lurasidone Extended Use Study

Poland

Romania

Russian Federation

Nizhniy Novgorod : Forest Investigative Site 603

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 604

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 602

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 606

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 608

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Slovakia

South Africa

Pretoria : Dey Clinic

Lurasidone Extended Use Study

Tygervalley : Cape Trial Centre

Lurasidone Extended Use Study

Switzerland

Basel : University Hospital Basel

General Practice Research Database Seroquel XR Safety Study

Taiwan

Tainan : Ru-Band Lu

Add-on Dextromethorphan in Bipolar Disorders

Ukraine

Dnipropetrovsk : Dnipropetrovsk Regional Clinical Hospital named Mechnikov

Lurasidone Extended Use Study

Donetsk : Regional Clinical Psychiatric Hospital, Dept #11

Lurasidone Extended Use Study

Kharkiv : Forest Investigative Site 703

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kharkov : Forest Investigative Site 704

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kherson : Kherson Regional Psychiatric Hospital

Lurasidone Extended Use Study

View More »

Kyiv : Forest Investigative Site 701

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Simferopol : Crimean republican Clinical Psychiatric Hospital

Lurasidone Extended Use Study

Simferopol : Forest Investigative Site 706

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Vinnitsa : Forest Investigative Site 705

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Vinnitsia : Reg. Psych. Hosp.n.a.O.Yuschenko, Dept #21

Lurasidone Extended Use Study